Inventor
TAO MING
US24 patents
⚠️ This page may combine multiple inventors who share the name “TAO MING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CEPHALON INC
9 patentsUS7169802B2Jan 30, 2007
Fused pyrrolocarbazoles
CEPHALON INC18 citations92
US6500802B1Dec 31, 2002
Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
CEPHALON INC28 citations92
US7241779B2Jul 10, 2007
Fused pyrrolocarbazoles
CEPHALON INC13 citations83
US7671064B2Mar 2, 2010
Fused pyrrolocarbazoles
CEPHALON INC7 citations73
US5952328ASep 14, 1999
Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
CEPHALON INC11 citations73
US5639732AJun 17, 1997
Phosphorous-containing cysteine and serine protease inhibitors
CEPHALON INC1 citations52
US7514440B2Apr 7, 2009
Fused pyrrolocarbazoles
CEPHALON INC0 citations51
US6348448B1Feb 19, 2002
Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
CEPHALON INC1 citations51
US8383813B2Feb 26, 2013
Fused pyrrolocarbazoles
CEPHALON INC0 citations50
INCYTE CORP
7 patentsUS9321755B2Apr 26, 2016
Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
INCYTE CORP15 citations92
US11407750B2Aug 9, 2022
Derivatives of an FGFR inhibitor
INCYTE CORP16 citations90
US11472801B2Oct 18, 2022
Crystalline forms of a FGFR inhibitor and processes for preparing the same
INCYTE CORP9 citations84
US10280157B2May 7, 2019
Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
INCYTE CORP3 citations72
US9873688B2Jan 23, 2018
Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
INCYTE CORP2 citations72
US12168660B2Dec 17, 2024
Derivatives of an FGFR inhibitor
INCYTE CORP2 citations68
US12552792B2Feb 17, 2026
Solid forms of an FGFR inhibitor and processes for preparing the same
INCYTE CORP0 citations62
BACON EDWARD R
4 patentsUS8673916B2Mar 18, 2014
Methods of treating disorders mediated by histamine H3 receptors using pyridazinone derivatives
BACON EDWARD R7 citations82
US8513232B2Aug 20, 2013
Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands
BACON EDWARD R9 citations82
US8247414B2Aug 21, 2012
Pyridizinone derivatives and the use thereof as H3 inhibitors
BACON EDWARD R2 citations62
US8586588B2Nov 19, 2013
Aryl pyridazinone derivatives and their use as H3 receptor ligands
BACON EDWARD R2 citations61